Tech Company Financing Transactions

Alector Funding Round

Alector, based in San Francisco, scored $32.3 million in funding from Merck Capital Ventures, GV and Mission Bay Capital.

Transaction Overview

Company Name
Alector
Announced On
9/16/2015
Transaction Type
Venture Equity
Amount
$32,275,003
Round
Series C
Investors

Merck Capital Ventures (Lead Investor) (Josh Resnick)

GV (Krishna Yeshwant)

Mission Bay Capital

OrbiMed (Carl Gordon)

Polaris Partners (Terry McGuire)

Topspin Partners

Proceeds Purpose
The proceeds from this financing will enable Alector to broaden its drug pipeline and to advance its most promising drug candidates towards clinical trials.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
131 Oyster Point Blvd. 600
San Francisco, CA 94080
USA
Phone
(415) 231-5660
Website
www.alector.com
Email Address
[email protected]
Overview
Alector (Nasdaq: ALEC) is combining state-of-the-art antibody technology and recent discoveries in neuroimmunolgy and human genetics to develop novel therapeutics for Alzheimer's disease, other forms of dementia, and mechanistically related neurodegenerative disorders.
Profile
Alector LinkedIn Company Profile
Social Media
Alector Company Twitter Account
Company News
Alector News
Facebook
Alector on Facebook
YouTube
Alector on YouTube

Management Team

Title
Name
Email & Social
Chairman
Tillman Gerngross
  Tillman Gerngross LinkedIn Profile  Tillman Gerngross Twitter Account  Tillman Gerngross News  Tillman Gerngross on Facebook
Chief Executive Officer
Arnon Rosenthal
  Arnon Rosenthal LinkedIn Profile  Arnon Rosenthal Twitter Account  Arnon Rosenthal News  Arnon Rosenthal on Facebook
Chief Financial Officer
Calvin Yu
  Calvin Yu LinkedIn Profile  Calvin Yu Twitter Account  Calvin Yu News  Calvin Yu on Facebook
Chief Medical Officer
Robert Paul
  Robert Paul LinkedIn Profile  Robert Paul Twitter Account  Robert Paul News  Robert Paul on Facebook
VP - Bus. Development
Robert King
  Robert King LinkedIn Profile  Robert King Twitter Account  Robert King News  Robert King on Facebook
VP - Bus. Development
Sabah Oney
  Sabah Oney LinkedIn Profile  Sabah Oney Twitter Account  Sabah Oney News  Sabah Oney on Facebook
VP - General Counsel
Stephanie Yonker
  Stephanie Yonker LinkedIn Profile  Stephanie Yonker Twitter Account  Stephanie Yonker News  Stephanie Yonker on Facebook
VP - Human Resources
Clare Hunt
  Clare Hunt LinkedIn Profile  Clare Hunt Twitter Account  Clare Hunt News  Clare Hunt on Facebook
VP - Manufacturing
Christian Simonsen
  Christian Simonsen LinkedIn Profile  Christian Simonsen Twitter Account  Christian Simonsen News  Christian Simonsen on Facebook
VP - Operations
Omer Siddiqui
  Omer Siddiqui LinkedIn Profile  Omer Siddiqui Twitter Account  Omer Siddiqui News  Omer Siddiqui on Facebook
VP - R & D
Hua Long
  Hua Long LinkedIn Profile  Hua Long Twitter Account  Hua Long News  Hua Long on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/15/2015: Source3 venture capital transaction
Next: 9/16/2015: Omada Health venture capital transaction

 

Share this article

 

About Database of VC Transactions

We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.